| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug-Eluting Stents | 29 | 2024 | 681 | 6.510 |
Why?
|
| Stents | 65 | 2021 | 3177 | 5.880 |
Why?
|
| Models, Cardiovascular | 31 | 2024 | 981 | 5.250 |
Why?
|
| Endothelial Cells | 41 | 2023 | 3550 | 5.110 |
Why?
|
| Coronary Vessels | 49 | 2023 | 3095 | 4.020 |
Why?
|
| Arteries | 28 | 2024 | 1120 | 3.490 |
Why?
|
| Endothelium, Vascular | 58 | 2016 | 4433 | 3.350 |
Why?
|
| Coronary Restenosis | 12 | 2021 | 396 | 3.060 |
Why?
|
| Sirolimus | 19 | 2024 | 1533 | 2.840 |
Why?
|
| Drug Delivery Systems | 28 | 2021 | 2222 | 2.560 |
Why?
|
| Tissue Scaffolds | 10 | 2023 | 932 | 2.490 |
Why?
|
| Hemodynamics | 28 | 2024 | 4160 | 2.440 |
Why?
|
| Renal Artery | 11 | 2024 | 351 | 2.410 |
Why?
|
| Angioplasty, Balloon | 17 | 2020 | 589 | 2.370 |
Why?
|
| Tunica Intima | 25 | 2018 | 458 | 2.350 |
Why?
|
| Swine | 64 | 2024 | 5908 | 2.330 |
Why?
|
| Paclitaxel | 15 | 2023 | 1730 | 2.310 |
Why?
|
| Sympathectomy | 10 | 2024 | 70 | 2.270 |
Why?
|
| Absorbable Implants | 11 | 2024 | 338 | 2.180 |
Why?
|
| Blood Vessel Prosthesis | 8 | 2019 | 951 | 2.060 |
Why?
|
| Prosthesis Design | 19 | 2024 | 2114 | 2.030 |
Why?
|
| Iliac Artery | 15 | 2018 | 343 | 2.000 |
Why?
|
| Carotid Arteries | 19 | 2016 | 941 | 1.900 |
Why?
|
| Fibroblast Growth Factor 2 | 19 | 2012 | 592 | 1.770 |
Why?
|
| Denervation | 5 | 2019 | 265 | 1.720 |
Why?
|
| Cardiovascular Agents | 10 | 2023 | 840 | 1.690 |
Why?
|
| Polymers | 19 | 2022 | 1614 | 1.690 |
Why?
|
| Tomography, Optical Coherence | 12 | 2024 | 2917 | 1.610 |
Why?
|
| Muscle, Smooth, Vascular | 25 | 2013 | 1492 | 1.610 |
Why?
|
| Cell Communication | 12 | 2023 | 1654 | 1.540 |
Why?
|
| Thrombosis | 27 | 2018 | 2942 | 1.540 |
Why?
|
| Heparin | 26 | 2018 | 1632 | 1.500 |
Why?
|
| Animals | 233 | 2024 | 168202 | 1.480 |
Why?
|
| Coated Materials, Biocompatible | 7 | 2020 | 311 | 1.450 |
Why?
|
| Aorta | 23 | 2023 | 2041 | 1.440 |
Why?
|
| Biocompatible Materials | 20 | 2024 | 1683 | 1.410 |
Why?
|
| Plaque, Atherosclerotic | 17 | 2023 | 1533 | 1.370 |
Why?
|
| Femoral Artery | 8 | 2020 | 826 | 1.340 |
Why?
|
| Pharmacokinetics | 5 | 2015 | 86 | 1.330 |
Why?
|
| Neointima | 6 | 2018 | 133 | 1.300 |
Why?
|
| Monocytes | 14 | 2023 | 2565 | 1.290 |
Why?
|
| Coronary Artery Disease | 31 | 2024 | 6403 | 1.280 |
Why?
|
| Vascular Resistance | 5 | 2020 | 930 | 1.280 |
Why?
|
| Endovascular Procedures | 7 | 2019 | 2182 | 1.260 |
Why?
|
| Blood Vessels | 11 | 2022 | 1112 | 1.240 |
Why?
|
| Tissue Adhesives | 6 | 2024 | 173 | 1.210 |
Why?
|
| Materials Testing | 10 | 2022 | 863 | 1.200 |
Why?
|
| Aortic Valve Stenosis | 7 | 2023 | 2003 | 1.200 |
Why?
|
| Dextrans | 12 | 2024 | 573 | 1.170 |
Why?
|
| Extracellular Matrix | 13 | 2018 | 1718 | 1.150 |
Why?
|
| Prosthesis Failure | 3 | 2018 | 1204 | 1.130 |
Why?
|
| Shock, Cardiogenic | 6 | 2024 | 709 | 1.110 |
Why?
|
| Stress, Mechanical | 28 | 2023 | 1674 | 1.090 |
Why?
|
| Rabbits | 34 | 2024 | 4770 | 1.080 |
Why?
|
| Heart Ventricles | 9 | 2024 | 3796 | 1.080 |
Why?
|
| Kidney | 15 | 2024 | 7044 | 1.080 |
Why?
|
| Myocytes, Smooth Muscle | 8 | 2015 | 699 | 1.050 |
Why?
|
| Hypertension | 13 | 2024 | 8532 | 1.040 |
Why?
|
| Pulsatile Flow | 7 | 2024 | 320 | 1.030 |
Why?
|
| Vascular System Injuries | 3 | 2015 | 245 | 1.020 |
Why?
|
| Hyperplasia | 25 | 2018 | 1150 | 0.990 |
Why?
|
| Heart-Assist Devices | 6 | 2024 | 1288 | 0.990 |
Why?
|
| Uremia | 4 | 2017 | 202 | 0.980 |
Why?
|
| Hemorheology | 6 | 2019 | 144 | 0.970 |
Why?
|
| Glucuronidase | 3 | 2012 | 202 | 0.960 |
Why?
|
| Norepinephrine | 5 | 2020 | 898 | 0.940 |
Why?
|
| Atherosclerosis | 14 | 2022 | 3400 | 0.930 |
Why?
|
| Models, Biological | 16 | 2019 | 9461 | 0.920 |
Why?
|
| Neovascularization, Physiologic | 9 | 2016 | 1349 | 0.900 |
Why?
|
| Coronary Circulation | 16 | 2021 | 1569 | 0.900 |
Why?
|
| Liver Regeneration | 2 | 2016 | 213 | 0.900 |
Why?
|
| Hydrodynamics | 5 | 2021 | 168 | 0.900 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2012 | 537 | 0.890 |
Why?
|
| Polystyrenes | 2 | 2022 | 104 | 0.880 |
Why?
|
| Blood Flow Velocity | 13 | 2023 | 1369 | 0.870 |
Why?
|
| Cattle | 27 | 2011 | 3841 | 0.850 |
Why?
|
| Gelatin | 3 | 2012 | 220 | 0.840 |
Why?
|
| Gelatin Sponge, Absorbable | 8 | 2013 | 55 | 0.830 |
Why?
|
| Hydrogels | 7 | 2024 | 720 | 0.830 |
Why?
|
| Coronary Angiography | 17 | 2021 | 4470 | 0.810 |
Why?
|
| Cells, Cultured | 37 | 2023 | 18937 | 0.800 |
Why?
|
| Imaging, Three-Dimensional | 10 | 2023 | 4058 | 0.790 |
Why?
|
| Models, Animal | 11 | 2019 | 2108 | 0.780 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2020 | 398 | 0.780 |
Why?
|
| Tissue Distribution | 15 | 2019 | 2261 | 0.770 |
Why?
|
| Ventricular Function, Left | 8 | 2024 | 3873 | 0.760 |
Why?
|
| Cell Division | 27 | 2005 | 4457 | 0.760 |
Why?
|
| Pharmaceutical Preparations | 9 | 2016 | 1086 | 0.760 |
Why?
|
| Carotid Artery Injuries | 6 | 2009 | 96 | 0.750 |
Why?
|
| Catheter Ablation | 9 | 2024 | 2634 | 0.740 |
Why?
|
| Angioplasty | 6 | 2020 | 355 | 0.740 |
Why?
|
| Glycyrrhetinic Acid | 1 | 2020 | 15 | 0.730 |
Why?
|
| Glycyrrhiza | 1 | 2020 | 9 | 0.730 |
Why?
|
| Mineralocorticoids | 1 | 2020 | 37 | 0.720 |
Why?
|
| Cardiac Output | 2 | 2020 | 831 | 0.720 |
Why?
|
| Humans | 221 | 2024 | 760740 | 0.720 |
Why?
|
| Ventricular Pressure | 3 | 2022 | 210 | 0.720 |
Why?
|
| Pheochromocytoma | 4 | 2009 | 328 | 0.710 |
Why?
|
| Nanomedicine | 1 | 2023 | 289 | 0.700 |
Why?
|
| Myocardial Revascularization | 4 | 2015 | 790 | 0.690 |
Why?
|
| Peripheral Arterial Disease | 3 | 2021 | 1271 | 0.680 |
Why?
|
| Angioplasty, Balloon, Coronary | 10 | 2016 | 1723 | 0.680 |
Why?
|
| Rats | 48 | 2015 | 23716 | 0.670 |
Why?
|
| Cell Transplantation | 5 | 2009 | 472 | 0.670 |
Why?
|
| Enzymes | 3 | 2006 | 257 | 0.670 |
Why?
|
| Catheterization, Peripheral | 2 | 2016 | 343 | 0.660 |
Why?
|
| Heparitin Sulfate | 5 | 2000 | 223 | 0.660 |
Why?
|
| Diffusion | 13 | 2009 | 814 | 0.660 |
Why?
|
| Rats, Sprague-Dawley | 31 | 2015 | 8165 | 0.660 |
Why?
|
| Tissue Engineering | 7 | 2023 | 1865 | 0.650 |
Why?
|
| Bioprosthesis | 4 | 2014 | 591 | 0.620 |
Why?
|
| Collagen | 6 | 2022 | 2634 | 0.610 |
Why?
|
| Delayed-Action Preparations | 14 | 2018 | 962 | 0.600 |
Why?
|
| Cell Adhesion | 12 | 2015 | 3088 | 0.600 |
Why?
|
| Smad2 Protein | 1 | 2018 | 145 | 0.590 |
Why?
|
| Alendronate | 2 | 2012 | 175 | 0.580 |
Why?
|
| Carotid Artery, Common | 5 | 2003 | 175 | 0.580 |
Why?
|
| Embolism | 2 | 2020 | 399 | 0.580 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2020 | 1400 | 0.570 |
Why?
|
| Kinetics | 19 | 2019 | 6370 | 0.570 |
Why?
|
| Aortic Coarctation | 2 | 2016 | 275 | 0.570 |
Why?
|
| Hyperaldosteronism | 1 | 2020 | 247 | 0.570 |
Why?
|
| Adrenal Gland Neoplasms | 4 | 2009 | 732 | 0.570 |
Why?
|
| Catheters | 1 | 2020 | 423 | 0.560 |
Why?
|
| Computer Simulation | 21 | 2024 | 6233 | 0.550 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2018 | 302 | 0.540 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2018 | 266 | 0.530 |
Why?
|
| Myocardial Contraction | 9 | 2015 | 1515 | 0.520 |
Why?
|
| Heart Auscultation | 1 | 2015 | 33 | 0.520 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2015 | 1390 | 0.520 |
Why?
|
| Sus scrofa | 9 | 2024 | 428 | 0.520 |
Why?
|
| Cardiotonic Agents | 4 | 2015 | 539 | 0.510 |
Why?
|
| Blood Pressure | 10 | 2024 | 8473 | 0.510 |
Why?
|
| Stethoscopes | 1 | 2015 | 30 | 0.510 |
Why?
|
| Thromboplastin | 3 | 2015 | 286 | 0.500 |
Why?
|
| Hepatectomy | 2 | 2016 | 557 | 0.500 |
Why?
|
| Ultrasonography, Interventional | 11 | 2018 | 1496 | 0.500 |
Why?
|
| Dendrimers | 4 | 2022 | 72 | 0.500 |
Why?
|
| Disease Models, Animal | 29 | 2024 | 18220 | 0.500 |
Why?
|
| Aortic Aneurysm | 2 | 2018 | 648 | 0.490 |
Why?
|
| Equipment Failure | 2 | 2016 | 577 | 0.490 |
Why?
|
| Wound Healing | 9 | 2024 | 2802 | 0.490 |
Why?
|
| Lymphocyte Activation | 5 | 2022 | 5463 | 0.490 |
Why?
|
| Electric Impedance | 1 | 2019 | 751 | 0.490 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2017 | 620 | 0.490 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2017 | 4340 | 0.480 |
Why?
|
| Biological Transport | 7 | 2017 | 2089 | 0.480 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2012 | 748 | 0.480 |
Why?
|
| Heart | 6 | 2024 | 4403 | 0.480 |
Why?
|
| Arteriosclerosis | 5 | 2004 | 1056 | 0.480 |
Why?
|
| Heparan Sulfate Proteoglycans | 5 | 2012 | 112 | 0.470 |
Why?
|
| Diabetes Mellitus, Experimental | 10 | 2021 | 1117 | 0.470 |
Why?
|
| Heart Valve Prosthesis | 4 | 2020 | 1462 | 0.470 |
Why?
|
| Intracranial Embolism | 1 | 2016 | 187 | 0.470 |
Why?
|
| Serum | 2 | 2012 | 208 | 0.470 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2024 | 1462 | 0.470 |
Why?
|
| Transforming Growth Factor beta | 6 | 2019 | 1962 | 0.460 |
Why?
|
| Models, Chemical | 3 | 2006 | 611 | 0.460 |
Why?
|
| Lactic Acid | 3 | 2012 | 1139 | 0.460 |
Why?
|
| Endothelium | 3 | 2021 | 764 | 0.460 |
Why?
|
| Interdisciplinary Studies | 1 | 2014 | 86 | 0.450 |
Why?
|
| Foreign-Body Migration | 1 | 2016 | 219 | 0.450 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2018 | 1222 | 0.450 |
Why?
|
| Cell Proliferation | 15 | 2022 | 10429 | 0.450 |
Why?
|
| Vasculitis | 5 | 2014 | 522 | 0.450 |
Why?
|
| Cell Adhesion Molecules | 5 | 2022 | 1602 | 0.450 |
Why?
|
| Coronary Artery Bypass | 5 | 2012 | 2188 | 0.450 |
Why?
|
| Heart Diseases | 2 | 2024 | 2778 | 0.440 |
Why?
|
| Vascular Surgical Procedures | 2 | 2021 | 1489 | 0.430 |
Why?
|
| Finite Element Analysis | 7 | 2023 | 437 | 0.430 |
Why?
|
| Coronary Thrombosis | 3 | 2012 | 440 | 0.420 |
Why?
|
| Chondroitin Sulfates | 3 | 2018 | 174 | 0.420 |
Why?
|
| Blood Vessel Prosthesis Implantation | 6 | 2019 | 1426 | 0.420 |
Why?
|
| Angina Pectoris | 4 | 2020 | 959 | 0.420 |
Why?
|
| Cell Movement | 10 | 2018 | 5201 | 0.420 |
Why?
|
| Glucose | 5 | 2013 | 4345 | 0.410 |
Why?
|
| Biomedical Research | 4 | 2019 | 3426 | 0.410 |
Why?
|
| Basement Membrane | 2 | 2018 | 349 | 0.410 |
Why?
|
| C-Reactive Protein | 6 | 2018 | 3820 | 0.410 |
Why?
|
| Inflammation | 16 | 2023 | 10759 | 0.400 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2020 | 1551 | 0.400 |
Why?
|
| Coculture Techniques | 7 | 2013 | 1336 | 0.400 |
Why?
|
| Paracrine Communication | 2 | 2011 | 277 | 0.400 |
Why?
|
| Immunity, Innate | 5 | 2015 | 3045 | 0.400 |
Why?
|
| Electrocardiography | 4 | 2011 | 6346 | 0.400 |
Why?
|
| Calcinosis | 2 | 2017 | 1469 | 0.390 |
Why?
|
| Heart Failure | 6 | 2024 | 11670 | 0.390 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2007 | 290 | 0.390 |
Why?
|
| Receptors, Growth Factor | 2 | 2010 | 326 | 0.390 |
Why?
|
| Glycemic Index | 1 | 2014 | 396 | 0.390 |
Why?
|
| Echocardiography | 5 | 2015 | 4987 | 0.380 |
Why?
|
| Coronary Sinus | 3 | 2020 | 84 | 0.380 |
Why?
|
| Chemokine CCL2 | 2 | 2012 | 602 | 0.380 |
Why?
|
| Medical Informatics | 1 | 2018 | 732 | 0.380 |
Why?
|
| Swine, Miniature | 4 | 2018 | 961 | 0.380 |
Why?
|
| Polyesters | 3 | 2020 | 371 | 0.370 |
Why?
|
| Dobutamine | 1 | 2011 | 116 | 0.370 |
Why?
|
| Regional Blood Flow | 5 | 2018 | 1496 | 0.360 |
Why?
|
| Male | 91 | 2024 | 360402 | 0.360 |
Why?
|
| Epithelial Cells | 4 | 2022 | 3672 | 0.360 |
Why?
|
| Mice | 36 | 2023 | 81368 | 0.360 |
Why?
|
| Social Change | 1 | 2011 | 153 | 0.360 |
Why?
|
| Shear Strength | 5 | 2016 | 160 | 0.360 |
Why?
|
| Microvessels | 3 | 2016 | 577 | 0.350 |
Why?
|
| Angiopoietin-1 | 1 | 2011 | 122 | 0.350 |
Why?
|
| Heart Arrest | 2 | 2011 | 1513 | 0.350 |
Why?
|
| Receptor, TIE-2 | 1 | 2011 | 176 | 0.350 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2009 | 222 | 0.350 |
Why?
|
| Ribosomal Protein S6 | 1 | 2010 | 71 | 0.350 |
Why?
|
| Vascular Diseases | 7 | 2009 | 1159 | 0.350 |
Why?
|
| Prostheses and Implants | 4 | 2022 | 1269 | 0.350 |
Why?
|
| Stroke Volume | 5 | 2020 | 5486 | 0.350 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2019 | 10754 | 0.340 |
Why?
|
| Cytoskeleton | 2 | 2012 | 1170 | 0.340 |
Why?
|
| Diabetic Angiopathies | 3 | 2012 | 803 | 0.340 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2010 | 459 | 0.340 |
Why?
|
| Proteoglycans | 4 | 2000 | 803 | 0.340 |
Why?
|
| Pancreas, Artificial | 1 | 2010 | 54 | 0.330 |
Why?
|
| Treatment Outcome | 28 | 2024 | 64572 | 0.330 |
Why?
|
| Solubility | 5 | 2019 | 1089 | 0.330 |
Why?
|
| Ventricular Septal Rupture | 1 | 2009 | 17 | 0.330 |
Why?
|
| Weight-Bearing | 2 | 2009 | 532 | 0.330 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 685 | 0.320 |
Why?
|
| Industry | 1 | 2011 | 364 | 0.320 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 1023 | 0.320 |
Why?
|
| Th2 Cells | 2 | 2016 | 1056 | 0.320 |
Why?
|
| Oligonucleotides, Antisense | 6 | 1997 | 458 | 0.320 |
Why?
|
| Anticoagulants | 10 | 2018 | 4785 | 0.320 |
Why?
|
| Fibroblast Growth Factors | 3 | 2009 | 865 | 0.320 |
Why?
|
| Viscoelastic Substances | 1 | 2008 | 20 | 0.320 |
Why?
|
| Time Factors | 26 | 2024 | 39908 | 0.320 |
Why?
|
| Science | 1 | 2011 | 239 | 0.320 |
Why?
|
| Hypothermia, Induced | 2 | 2011 | 754 | 0.310 |
Why?
|
| Sympathetic Nervous System | 3 | 2023 | 519 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2010 | 571 | 0.310 |
Why?
|
| Apoptosis | 7 | 2018 | 9476 | 0.310 |
Why?
|
| Cardiology | 2 | 2018 | 1656 | 0.310 |
Why?
|
| Phospholipase C beta | 1 | 2008 | 49 | 0.310 |
Why?
|
| Isometric Contraction | 1 | 2009 | 150 | 0.310 |
Why?
|
| Hyperlipidemias | 2 | 2010 | 770 | 0.310 |
Why?
|
| Polytetrafluoroethylene | 2 | 2000 | 245 | 0.300 |
Why?
|
| Kidney Failure, Chronic | 3 | 2021 | 2474 | 0.300 |
Why?
|
| Polyglycolic Acid | 3 | 2023 | 406 | 0.300 |
Why?
|
| Immunosuppressive Agents | 4 | 2016 | 4172 | 0.300 |
Why?
|
| Signal Transduction | 13 | 2021 | 23415 | 0.300 |
Why?
|
| Cardiovascular Diseases | 7 | 2023 | 15498 | 0.300 |
Why?
|
| Drug Implants | 6 | 2004 | 230 | 0.300 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 2100 | 0.290 |
Why?
|
| History, 18th Century | 3 | 2016 | 206 | 0.290 |
Why?
|
| Liver | 5 | 2022 | 7512 | 0.290 |
Why?
|
| Growth Substances | 2 | 2008 | 768 | 0.290 |
Why?
|
| Equipment Design | 13 | 2018 | 3501 | 0.290 |
Why?
|
| Connective Tissue | 2 | 2007 | 419 | 0.290 |
Why?
|
| Aldehydes | 1 | 2008 | 170 | 0.290 |
Why?
|
| Pressure | 5 | 2019 | 1150 | 0.290 |
Why?
|
| Transplantation, Homologous | 6 | 2022 | 4802 | 0.290 |
Why?
|
| Polyethylene Glycols | 6 | 2022 | 1182 | 0.290 |
Why?
|
| Research Personnel | 1 | 2012 | 588 | 0.280 |
Why?
|
| Culture Media, Conditioned | 6 | 2016 | 522 | 0.280 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2018 | 1810 | 0.280 |
Why?
|
| Neovascularization, Pathologic | 6 | 2013 | 2644 | 0.280 |
Why?
|
| Antibody Formation | 3 | 2008 | 1390 | 0.280 |
Why?
|
| Body Temperature | 1 | 2010 | 780 | 0.280 |
Why?
|
| Epinephrine | 3 | 2015 | 792 | 0.270 |
Why?
|
| Liver Diseases | 1 | 2015 | 1297 | 0.270 |
Why?
|
| Organ Specificity | 2 | 2012 | 1964 | 0.270 |
Why?
|
| Computational Biology | 1 | 2018 | 3509 | 0.270 |
Why?
|
| Immunity, Cellular | 3 | 2008 | 1550 | 0.270 |
Why?
|
| Jugular Veins | 1 | 2007 | 210 | 0.260 |
Why?
|
| Receptors, Cell Surface | 3 | 2016 | 2802 | 0.260 |
Why?
|
| Algorithms | 11 | 2021 | 14024 | 0.260 |
Why?
|
| Coronary Disease | 7 | 2000 | 5911 | 0.260 |
Why?
|
| Diabetes Mellitus | 3 | 2014 | 5838 | 0.260 |
Why?
|
| Microcirculation | 3 | 2009 | 1272 | 0.260 |
Why?
|
| Bronchi | 1 | 2010 | 846 | 0.260 |
Why?
|
| History, 19th Century | 3 | 2016 | 718 | 0.260 |
Why?
|
| Aortography | 2 | 2018 | 421 | 0.250 |
Why?
|
| Clinical Trials as Topic | 5 | 2017 | 7995 | 0.250 |
Why?
|
| Perfusion | 5 | 2019 | 1373 | 0.250 |
Why?
|
| Cell Culture Techniques | 5 | 2016 | 1662 | 0.250 |
Why?
|
| Protamines | 2 | 1997 | 112 | 0.250 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2008 | 528 | 0.250 |
Why?
|
| Blood Circulation | 1 | 2006 | 248 | 0.250 |
Why?
|
| Stromal Cells | 1 | 2011 | 1329 | 0.250 |
Why?
|
| Graft Rejection | 4 | 2014 | 4438 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1650 | 0.250 |
Why?
|
| Female | 64 | 2024 | 392203 | 0.250 |
Why?
|
| Phosphorylation | 8 | 2018 | 8311 | 0.240 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 574 | 0.240 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 4910 | 0.240 |
Why?
|
| Catheterization | 6 | 2004 | 1428 | 0.240 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 1727 | 0.240 |
Why?
|
| Macrophages | 9 | 2023 | 5758 | 0.240 |
Why?
|
| Structure-Activity Relationship | 3 | 2009 | 3074 | 0.240 |
Why?
|
| Chemokines | 1 | 2009 | 954 | 0.240 |
Why?
|
| Molecular Imaging | 1 | 2011 | 814 | 0.230 |
Why?
|
| Sweetening Agents | 1 | 2007 | 290 | 0.230 |
Why?
|
| Echocardiography, Doppler | 2 | 2020 | 893 | 0.230 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2004 | 420 | 0.230 |
Why?
|
| Nanostructures | 2 | 2023 | 551 | 0.230 |
Why?
|
| Neoplasms | 6 | 2015 | 22131 | 0.230 |
Why?
|
| Databases, Factual | 3 | 2017 | 7963 | 0.230 |
Why?
|
| Hypoglycemic Agents | 2 | 2014 | 3085 | 0.230 |
Why?
|
| Endosomes | 1 | 2007 | 522 | 0.230 |
Why?
|
| Liver Transplantation | 1 | 2016 | 2328 | 0.230 |
Why?
|
| Immunity | 2 | 2007 | 994 | 0.230 |
Why?
|
| Intracranial Aneurysm | 1 | 2014 | 1285 | 0.230 |
Why?
|
| Umbilical Veins | 3 | 2010 | 426 | 0.220 |
Why?
|
| Sex Factors | 1 | 2018 | 10549 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 2015 | 120 | 0.220 |
Why?
|
| Constriction, Pathologic | 6 | 2012 | 1096 | 0.220 |
Why?
|
| Vasodilation | 4 | 2017 | 962 | 0.220 |
Why?
|
| Random Allocation | 3 | 2019 | 2392 | 0.220 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2018 | 631 | 0.220 |
Why?
|
| Pericardium | 4 | 2018 | 664 | 0.220 |
Why?
|
| Elasticity | 4 | 2021 | 655 | 0.220 |
Why?
|
| Platelet Aggregation | 1 | 2007 | 771 | 0.220 |
Why?
|
| Muscle, Skeletal | 2 | 2009 | 4947 | 0.220 |
Why?
|
| Epithelium | 1 | 2008 | 1603 | 0.220 |
Why?
|
| Publications | 2 | 2018 | 194 | 0.210 |
Why?
|
| Diabetes Complications | 1 | 2010 | 1315 | 0.210 |
Why?
|
| NF-kappa B | 2 | 2009 | 2481 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2872 | 0.210 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2020 | 614 | 0.210 |
Why?
|
| Thrombolytic Therapy | 2 | 2023 | 2055 | 0.200 |
Why?
|
| Excipients | 2 | 2020 | 98 | 0.200 |
Why?
|
| Polyvinyls | 8 | 1998 | 154 | 0.200 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2001 | 2048 | 0.200 |
Why?
|
| Physician-Patient Relations | 1 | 2015 | 3239 | 0.200 |
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2014 | 705 | 0.200 |
Why?
|
| X-Ray Microtomography | 3 | 2021 | 455 | 0.200 |
Why?
|
| Myocardium | 7 | 2015 | 4725 | 0.200 |
Why?
|
| Plethysmography | 1 | 2022 | 175 | 0.200 |
Why?
|
| Transplantation, Heterologous | 6 | 2007 | 2382 | 0.200 |
Why?
|
| Capillary Permeability | 3 | 2016 | 773 | 0.200 |
Why?
|
| Aortic Valve | 3 | 2023 | 1955 | 0.190 |
Why?
|
| Cell Survival | 4 | 2015 | 5780 | 0.190 |
Why?
|
| Immunohistochemistry | 6 | 2019 | 11069 | 0.190 |
Why?
|
| COUP Transcription Factor II | 1 | 2021 | 18 | 0.190 |
Why?
|
| Carotid Artery, Internal | 1 | 2004 | 445 | 0.190 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 370 | 0.190 |
Why?
|
| Registries | 1 | 2017 | 8209 | 0.190 |
Why?
|
| Fatal Outcome | 2 | 2020 | 1835 | 0.180 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2021 | 63 | 0.180 |
Why?
|
| Gold | 2 | 2004 | 481 | 0.180 |
Why?
|
| Carotid Artery Diseases | 2 | 2021 | 877 | 0.180 |
Why?
|
| Predictive Value of Tests | 9 | 2021 | 15250 | 0.180 |
Why?
|
| Biopsy, Needle | 2 | 2019 | 1624 | 0.180 |
Why?
|
| Blood Proteins | 2 | 2004 | 1172 | 0.180 |
Why?
|
| Respiratory Rate | 1 | 2022 | 175 | 0.180 |
Why?
|
| Ketones | 1 | 2022 | 183 | 0.180 |
Why?
|
| Gene Expression | 5 | 2016 | 7569 | 0.180 |
Why?
|
| Platelet Activation | 1 | 2004 | 646 | 0.180 |
Why?
|
| Hepatic Artery | 1 | 2022 | 232 | 0.180 |
Why?
|
| Polyethylene | 1 | 2022 | 185 | 0.180 |
Why?
|
| Receptors, Immunologic | 4 | 2016 | 1409 | 0.180 |
Why?
|
| Liver Cirrhosis | 2 | 2023 | 1927 | 0.180 |
Why?
|
| Laminin | 1 | 2002 | 408 | 0.180 |
Why?
|
| Protein Binding | 7 | 2009 | 9345 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2008 | 3798 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 10 | 2019 | 22117 | 0.180 |
Why?
|
| United States Food and Drug Administration | 3 | 2020 | 1661 | 0.170 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 110 | 0.170 |
Why?
|
| Aorta, Abdominal | 2 | 2009 | 625 | 0.170 |
Why?
|
| Nickel | 1 | 2020 | 128 | 0.170 |
Why?
|
| Endocytosis | 1 | 2004 | 955 | 0.170 |
Why?
|
| Ventricular Function, Right | 1 | 2024 | 617 | 0.170 |
Why?
|
| Blood Pressure Determination | 2 | 2021 | 633 | 0.170 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 1997 | 178 | 0.170 |
Why?
|
| Myocardial Infarction | 7 | 2020 | 11458 | 0.170 |
Why?
|
| Heart Valves | 2 | 2020 | 284 | 0.170 |
Why?
|
| Speech | 2 | 2021 | 555 | 0.170 |
Why?
|
| Fibrinolytic Agents | 4 | 2023 | 2073 | 0.170 |
Why?
|
| Surface Properties | 5 | 2017 | 1162 | 0.170 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2005 | 974 | 0.170 |
Why?
|
| Culture Media | 2 | 2012 | 895 | 0.170 |
Why?
|
| Alginates | 8 | 2022 | 248 | 0.170 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2007 | 274 | 0.170 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 2191 | 0.170 |
Why?
|
| Forelimb | 1 | 2019 | 116 | 0.170 |
Why?
|
| Blotting, Western | 3 | 2015 | 5034 | 0.170 |
Why?
|
| Hypokalemia | 1 | 2020 | 153 | 0.170 |
Why?
|
| Ganglia | 1 | 2019 | 86 | 0.160 |
Why?
|
| Joints | 1 | 2001 | 322 | 0.160 |
Why?
|
| Molecular Weight | 4 | 2010 | 2185 | 0.160 |
Why?
|
| Carrier Proteins | 4 | 2018 | 4937 | 0.160 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2013 | 1128 | 0.160 |
Why?
|
| Spleen | 4 | 2009 | 2286 | 0.160 |
Why?
|
| Tissue Preservation | 1 | 2019 | 174 | 0.160 |
Why?
|
| Magnetics | 4 | 1993 | 597 | 0.160 |
Why?
|
| Disease Progression | 11 | 2021 | 13495 | 0.160 |
Why?
|
| beta Catenin | 2 | 2015 | 1039 | 0.160 |
Why?
|
| PC12 Cells | 2 | 2009 | 317 | 0.160 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2023 | 1553 | 0.160 |
Why?
|
| Stainless Steel | 3 | 2004 | 79 | 0.160 |
Why?
|
| Middle Aged | 31 | 2021 | 220603 | 0.160 |
Why?
|
| Serum Albumin | 1 | 2002 | 673 | 0.160 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2019 | 142 | 0.160 |
Why?
|
| Blood Chemical Analysis | 1 | 2020 | 436 | 0.160 |
Why?
|
| Polyurethanes | 1 | 2019 | 109 | 0.160 |
Why?
|
| Biotechnology | 2 | 2018 | 281 | 0.160 |
Why?
|
| Endothelial Growth Factors | 3 | 1998 | 673 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2024 | 10203 | 0.150 |
Why?
|
| Replantation | 1 | 2019 | 145 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 6345 | 0.150 |
Why?
|
| Cardiomyopathies | 2 | 2009 | 1948 | 0.150 |
Why?
|
| Fibronectins | 1 | 2002 | 723 | 0.150 |
Why?
|
| Insulin | 7 | 2010 | 6593 | 0.150 |
Why?
|
| Ubiquitination | 2 | 2013 | 1006 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 5369 | 0.150 |
Why?
|
| Cholesterol, Dietary | 1 | 2018 | 224 | 0.150 |
Why?
|
| Cytotoxins | 1 | 1998 | 153 | 0.150 |
Why?
|
| Graphite | 1 | 2018 | 78 | 0.150 |
Why?
|
| Lymphokines | 3 | 1998 | 925 | 0.150 |
Why?
|
| Phenotype | 5 | 2022 | 16572 | 0.150 |
Why?
|
| Chondrocytes | 1 | 2023 | 792 | 0.150 |
Why?
|
| Ventricular Fibrillation | 1 | 2020 | 534 | 0.150 |
Why?
|
| Titanium | 1 | 2020 | 485 | 0.150 |
Why?
|
| Fishes | 1 | 2001 | 602 | 0.150 |
Why?
|
| Iohexol | 2 | 2017 | 204 | 0.150 |
Why?
|
| Blood Glucose | 5 | 2018 | 6390 | 0.150 |
Why?
|
| Fibroblasts | 3 | 2022 | 4140 | 0.150 |
Why?
|
| History, 20th Century | 3 | 2018 | 2764 | 0.150 |
Why?
|
| Cycloheximide | 1 | 2017 | 343 | 0.140 |
Why?
|
| Vascular Grafting | 1 | 2019 | 162 | 0.140 |
Why?
|
| Cytokines | 5 | 2023 | 7373 | 0.140 |
Why?
|
| Reproducibility of Results | 7 | 2021 | 20077 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2018 | 2057 | 0.140 |
Why?
|
| Cartilage | 1 | 2001 | 806 | 0.140 |
Why?
|
| Reference Values | 3 | 2019 | 4919 | 0.140 |
Why?
|
| Blood Viscosity | 2 | 2008 | 124 | 0.140 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 11874 | 0.140 |
Why?
|
| Platelet Activating Factor | 1 | 1997 | 143 | 0.140 |
Why?
|
| Indican | 2 | 2015 | 16 | 0.140 |
Why?
|
| Renal Dialysis | 3 | 2021 | 1795 | 0.140 |
Why?
|
| Electrodes | 1 | 2019 | 610 | 0.140 |
Why?
|
| Nanocomposites | 1 | 2017 | 49 | 0.140 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2018 | 273 | 0.140 |
Why?
|
| Tachycardia | 3 | 2015 | 597 | 0.140 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 836 | 0.140 |
Why?
|
| Fluorescein | 2 | 2011 | 175 | 0.140 |
Why?
|
| Leukocytes | 2 | 2004 | 2024 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4569 | 0.140 |
Why?
|
| Busulfan | 1 | 1997 | 258 | 0.140 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2021 | 709 | 0.140 |
Why?
|
| Mice, Transgenic | 5 | 2012 | 9526 | 0.130 |
Why?
|
| Retrospective Studies | 8 | 2024 | 80583 | 0.130 |
Why?
|
| Catecholamines | 3 | 2020 | 387 | 0.130 |
Why?
|
| Lamivudine | 1 | 2018 | 366 | 0.130 |
Why?
|
| Diterpenes | 1 | 1997 | 170 | 0.130 |
Why?
|
| Models, Molecular | 2 | 2003 | 5433 | 0.130 |
Why?
|
| Drug Carriers | 7 | 2000 | 706 | 0.130 |
Why?
|
| Plant Proteins | 1 | 1998 | 369 | 0.130 |
Why?
|
| Research | 2 | 2017 | 1977 | 0.130 |
Why?
|
| Muscles | 1 | 2001 | 1573 | 0.130 |
Why?
|
| Culture Techniques | 3 | 2004 | 531 | 0.130 |
Why?
|
| Microscopy, Atomic Force | 2 | 2022 | 253 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2007 | 2722 | 0.130 |
Why?
|
| History, 17th Century | 1 | 2016 | 108 | 0.130 |
Why?
|
| Neoplasm Transplantation | 2 | 2011 | 2010 | 0.130 |
Why?
|
| Solutions | 4 | 2019 | 412 | 0.130 |
Why?
|
| Zidovudine | 1 | 2018 | 624 | 0.130 |
Why?
|
| Aorta, Thoracic | 2 | 2022 | 1096 | 0.130 |
Why?
|
| Amides | 1 | 1998 | 449 | 0.130 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2018 | 237 | 0.130 |
Why?
|
| Wounds and Injuries | 2 | 2008 | 2492 | 0.130 |
Why?
|
| Magnesium | 1 | 2019 | 804 | 0.130 |
Why?
|
| Cell Line | 6 | 2015 | 15577 | 0.130 |
Why?
|
| Health Care Sector | 1 | 2017 | 195 | 0.130 |
Why?
|
| Hyperglycemia | 2 | 2005 | 1375 | 0.130 |
Why?
|
| Rheology | 1 | 2017 | 347 | 0.130 |
Why?
|
| Arginase | 1 | 2016 | 78 | 0.130 |
Why?
|
| Infusions, Intravenous | 6 | 2014 | 2214 | 0.130 |
Why?
|
| Robotics | 1 | 2022 | 817 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2010 | 3415 | 0.130 |
Why?
|
| Aldosterone | 1 | 2020 | 869 | 0.130 |
Why?
|
| Fracture Healing | 2 | 2017 | 445 | 0.130 |
Why?
|
| Aftercare | 1 | 2021 | 913 | 0.130 |
Why?
|
| Extremities | 1 | 2001 | 867 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2023 | 2013 | 0.130 |
Why?
|
| Causality | 1 | 2001 | 1241 | 0.120 |
Why?
|
| Intestine, Small | 3 | 2012 | 1207 | 0.120 |
Why?
|
| Hypercholesterolemia | 4 | 2021 | 1141 | 0.120 |
Why?
|
| Equipment and Supplies | 1 | 2017 | 273 | 0.120 |
Why?
|
| Transaminases | 1 | 2016 | 199 | 0.120 |
Why?
|
| Artifacts | 1 | 2024 | 1910 | 0.120 |
Why?
|
| Interferon-gamma | 4 | 2013 | 3145 | 0.120 |
Why?
|
| Skull | 1 | 2019 | 818 | 0.120 |
Why?
|
| Pancreas | 1 | 2022 | 1691 | 0.120 |
Why?
|
| Matrix Metalloproteinases | 3 | 2013 | 391 | 0.120 |
Why?
|
| Amyloid beta-Peptides | 1 | 2008 | 3839 | 0.120 |
Why?
|
| Inflammation Mediators | 2 | 2018 | 1884 | 0.120 |
Why?
|
| External Fixators | 1 | 2015 | 98 | 0.120 |
Why?
|
| Somatostatin | 1 | 1996 | 447 | 0.120 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2018 | 621 | 0.120 |
Why?
|
| Triiodobenzoic Acids | 1 | 2014 | 123 | 0.120 |
Why?
|
| Myocardial Ischemia | 6 | 2012 | 2110 | 0.120 |
Why?
|
| Private Sector | 1 | 2017 | 394 | 0.120 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2021 | 696 | 0.120 |
Why?
|
| Aged | 23 | 2023 | 169092 | 0.120 |
Why?
|
| Electromagnetic Phenomena | 2 | 1987 | 160 | 0.120 |
Why?
|
| Needles | 1 | 2017 | 450 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 1077 | 0.120 |
Why?
|
| beta-Alanine | 1 | 2015 | 82 | 0.120 |
Why?
|
| Interleukin-4 | 2 | 2009 | 1146 | 0.120 |
Why?
|
| Clinical Medicine | 1 | 2015 | 145 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1626 | 0.110 |
Why?
|
| Financing, Government | 1 | 2017 | 472 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 9417 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2004 | 944 | 0.110 |
Why?
|
| Sepharose | 3 | 2009 | 103 | 0.110 |
Why?
|
| Cell-Matrix Junctions | 1 | 2013 | 21 | 0.110 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 14649 | 0.110 |
Why?
|
| Drug Therapy | 1 | 1997 | 503 | 0.110 |
Why?
|
| Cyclic AMP | 2 | 2015 | 1463 | 0.110 |
Why?
|
| Genes, myc | 1 | 1995 | 390 | 0.110 |
Why?
|
| Catalysis | 2 | 2006 | 773 | 0.110 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2014 | 691 | 0.110 |
Why?
|
| Cell Cycle | 4 | 2008 | 2929 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2019 | 3730 | 0.110 |
Why?
|
| Angiography | 5 | 2019 | 1595 | 0.110 |
Why?
|
| Garlic | 1 | 2013 | 28 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2021 | 1002 | 0.110 |
Why?
|
| Ligands | 3 | 2007 | 3268 | 0.110 |
Why?
|
| Interleukin-6 | 2 | 2015 | 3205 | 0.110 |
Why?
|
| Blood Coagulation | 4 | 2007 | 1154 | 0.110 |
Why?
|
| Plasmids | 1 | 2018 | 2265 | 0.110 |
Why?
|
| Immunotherapy | 2 | 2023 | 4642 | 0.110 |
Why?
|
| Tight Junctions | 1 | 2016 | 324 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2002 | 1310 | 0.110 |
Why?
|
| Collagen Type IV | 1 | 2013 | 126 | 0.110 |
Why?
|
| Femoral Fractures | 1 | 2017 | 375 | 0.110 |
Why?
|
| Bone Substitutes | 1 | 2015 | 236 | 0.110 |
Why?
|
| DNA Replication | 1 | 2020 | 1414 | 0.110 |
Why?
|
| Acute Disease | 2 | 2021 | 7236 | 0.110 |
Why?
|
| Indoleacetic Acids | 1 | 2012 | 44 | 0.110 |
Why?
|
| Hexuronic Acids | 6 | 2013 | 145 | 0.110 |
Why?
|
| Glucuronic Acid | 6 | 2013 | 150 | 0.110 |
Why?
|
| Punctures | 2 | 2010 | 364 | 0.110 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 220 | 0.100 |
Why?
|
| Viral Proteins | 1 | 2020 | 1799 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2022 | 4210 | 0.100 |
Why?
|
| Oxygen | 1 | 2024 | 4226 | 0.100 |
Why?
|
| Epoprostenol | 2 | 2005 | 247 | 0.100 |
Why?
|
| Procollagen | 1 | 2013 | 187 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2019 | 1270 | 0.100 |
Why?
|
| Mathematics | 2 | 2006 | 707 | 0.100 |
Why?
|
| Phantoms, Imaging | 2 | 2017 | 2518 | 0.100 |
Why?
|
| Drug Administration Routes | 2 | 2011 | 150 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2020 | 992 | 0.100 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2018 | 556 | 0.100 |
Why?
|
| Plant Preparations | 1 | 2013 | 94 | 0.100 |
Why?
|
| Hydrocortisone | 1 | 2020 | 1819 | 0.100 |
Why?
|
| Leukocyte Count | 4 | 2003 | 1597 | 0.100 |
Why?
|
| Ventricular Function | 1 | 2014 | 406 | 0.100 |
Why?
|
| Syndecan-4 | 1 | 2012 | 45 | 0.100 |
Why?
|
| Vasa Vasorum | 1 | 1992 | 25 | 0.100 |
Why?
|
| Aortic Diseases | 1 | 2018 | 735 | 0.100 |
Why?
|
| Tunica Media | 1 | 2012 | 110 | 0.100 |
Why?
|
| Adhesives | 1 | 2012 | 66 | 0.100 |
Why?
|
| Metabolic Clearance Rate | 2 | 2004 | 361 | 0.100 |
Why?
|
| Cardiac Tamponade | 1 | 1993 | 173 | 0.100 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 58919 | 0.100 |
Why?
|
| Biology | 1 | 2014 | 290 | 0.100 |
Why?
|
| Injections, Intravenous | 4 | 2001 | 1376 | 0.100 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1992 | 191 | 0.100 |
Why?
|
| Tibial Fractures | 1 | 2015 | 272 | 0.100 |
Why?
|
| Proteolipids | 1 | 2012 | 113 | 0.100 |
Why?
|
| Ischemia | 2 | 2012 | 1885 | 0.100 |
Why?
|
| HLA-DR Antigens | 1 | 2013 | 601 | 0.100 |
Why?
|
| Elastic Modulus | 1 | 2012 | 211 | 0.100 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 12966 | 0.100 |
Why?
|
| Morpholines | 1 | 2015 | 581 | 0.100 |
Why?
|
| Guinea Pigs | 2 | 2024 | 1310 | 0.100 |
Why?
|
| Rats, Zucker | 2 | 2008 | 131 | 0.100 |
Why?
|
| Crystallization | 1 | 2012 | 533 | 0.090 |
Why?
|
| Porphyrins | 1 | 2013 | 352 | 0.090 |
Why?
|
| Hemorrhage | 3 | 2018 | 3418 | 0.090 |
Why?
|
| Collagen Type II | 1 | 2011 | 148 | 0.090 |
Why?
|
| Systole | 1 | 1993 | 935 | 0.090 |
Why?
|
| Risk Factors | 12 | 2023 | 74128 | 0.090 |
Why?
|
| Cholesterol | 4 | 2013 | 2902 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 4 | 2016 | 2639 | 0.090 |
Why?
|
| Adult | 17 | 2022 | 220995 | 0.090 |
Why?
|
| Microspheres | 4 | 2004 | 782 | 0.090 |
Why?
|
| Vascular Malformations | 1 | 2016 | 468 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 654 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 794 | 0.090 |
Why?
|
| Gelatinases | 1 | 2010 | 88 | 0.090 |
Why?
|
| Lung | 2 | 2008 | 9999 | 0.090 |
Why?
|
| Integrins | 2 | 2012 | 834 | 0.090 |
Why?
|
| Recurrence | 9 | 2007 | 8426 | 0.090 |
Why?
|
| Drug Resistance | 3 | 2016 | 1594 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2018 | 4117 | 0.090 |
Why?
|
| CHO Cells | 2 | 2008 | 1387 | 0.090 |
Why?
|
| Calcium | 4 | 2022 | 5717 | 0.090 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2014 | 607 | 0.090 |
Why?
|
| Thiophenes | 1 | 2015 | 569 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2022 | 3461 | 0.090 |
Why?
|
| Myocytes, Cardiac | 2 | 2009 | 1667 | 0.090 |
Why?
|
| Poloxamer | 2 | 2024 | 56 | 0.090 |
Why?
|
| Fracture Fixation, Internal | 1 | 2017 | 971 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 1997 | 859 | 0.090 |
Why?
|
| United States | 7 | 2020 | 72292 | 0.090 |
Why?
|
| Subcutaneous Tissue | 1 | 2010 | 132 | 0.090 |
Why?
|
| Compressive Strength | 1 | 2010 | 158 | 0.090 |
Why?
|
| Angiopoietin-2 | 1 | 2011 | 172 | 0.090 |
Why?
|
| Injections, Subcutaneous | 2 | 2006 | 671 | 0.080 |
Why?
|
| Antioxidants | 1 | 1998 | 1669 | 0.080 |
Why?
|
| Adhesiveness | 1 | 2009 | 52 | 0.080 |
Why?
|
| Levodopa | 1 | 2010 | 222 | 0.080 |
Why?
|
| Collagen Type I | 1 | 2013 | 616 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 5 | 1992 | 321 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 1431 | 0.080 |
Why?
|
| src-Family Kinases | 1 | 2012 | 535 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1997 | 1250 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2023 | 2568 | 0.080 |
Why?
|
| Heart Transplantation | 1 | 2003 | 3233 | 0.080 |
Why?
|
| Cricetinae | 2 | 2008 | 2424 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2015 | 858 | 0.080 |
Why?
|
| Tensile Strength | 1 | 2010 | 330 | 0.080 |
Why?
|
| Quality of Life | 3 | 2020 | 13359 | 0.080 |
Why?
|
| Lower Extremity | 1 | 2017 | 1200 | 0.080 |
Why?
|
| RNA, Messenger | 5 | 2009 | 12759 | 0.080 |
Why?
|
| Sheep | 3 | 2019 | 1436 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2013 | 3868 | 0.080 |
Why?
|
| Hemostatics | 2 | 2002 | 240 | 0.080 |
Why?
|
| Iodine Radioisotopes | 3 | 2000 | 1031 | 0.080 |
Why?
|
| Tissue Adhesions | 1 | 2010 | 218 | 0.080 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 1027 | 0.080 |
Why?
|
| Implants, Experimental | 1 | 2009 | 99 | 0.080 |
Why?
|
| Interleukin-1beta | 3 | 2010 | 998 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2015 | 3606 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2014 | 504 | 0.080 |
Why?
|
| Photosensitizing Agents | 1 | 2013 | 623 | 0.080 |
Why?
|
| Fatigue | 3 | 2022 | 1550 | 0.080 |
Why?
|
| Light | 1 | 2015 | 1352 | 0.080 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1992 | 253 | 0.080 |
Why?
|
| Chemokine CX3CL1 | 1 | 2009 | 62 | 0.080 |
Why?
|
| Uncertainty | 1 | 2014 | 752 | 0.080 |
Why?
|
| Double-Blind Method | 5 | 2020 | 12333 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2015 | 3802 | 0.080 |
Why?
|
| Protein Denaturation | 2 | 2003 | 242 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2023 | 8998 | 0.080 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 1013 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2011 | 731 | 0.080 |
Why?
|
| Biopolymers | 3 | 1997 | 183 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2021 | 3442 | 0.080 |
Why?
|
| Mitosis | 1 | 1993 | 1187 | 0.080 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 271 | 0.080 |
Why?
|
| Lipoproteins, LDL | 3 | 2018 | 642 | 0.080 |
Why?
|
| Rats, Inbred SHR | 1 | 2008 | 186 | 0.080 |
Why?
|
| Feasibility Studies | 5 | 2021 | 5239 | 0.080 |
Why?
|
| Spectrum Analysis | 1 | 2010 | 452 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 829 | 0.080 |
Why?
|
| Reoperation | 2 | 2010 | 4300 | 0.080 |
Why?
|
| RNA | 2 | 2015 | 2713 | 0.080 |
Why?
|
| Glycosaminoglycans | 2 | 2002 | 607 | 0.080 |
Why?
|
| Injections, Intralesional | 1 | 2009 | 280 | 0.080 |
Why?
|
| Normal Distribution | 2 | 2021 | 272 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 1894 | 0.080 |
Why?
|
| Drug Compounding | 2 | 2007 | 245 | 0.080 |
Why?
|
| T-Lymphocytes | 4 | 2013 | 10175 | 0.070 |
Why?
|
| Glucagon | 1 | 2010 | 531 | 0.070 |
Why?
|
| Photomicrography | 1 | 2007 | 71 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2015 | 2894 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2447 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2007 | 614 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2008 | 200 | 0.070 |
Why?
|
| Compliance | 2 | 2015 | 99 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3037 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3599 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2013 | 3492 | 0.070 |
Why?
|
| Electromagnetic Fields | 2 | 1992 | 289 | 0.070 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 555 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2008 | 169 | 0.070 |
Why?
|
| Prospective Studies | 10 | 2023 | 54364 | 0.070 |
Why?
|
| Umbilical Cord | 1 | 2008 | 177 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 613 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3527 | 0.070 |
Why?
|
| Neurotoxins | 1 | 2008 | 240 | 0.070 |
Why?
|
| 3T3 Cells | 3 | 1993 | 1085 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2015 | 1333 | 0.070 |
Why?
|
| Cyclosporine | 1 | 2009 | 776 | 0.070 |
Why?
|
| Models, Theoretical | 3 | 2014 | 3567 | 0.070 |
Why?
|
| Receptor Cross-Talk | 1 | 2007 | 115 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 16968 | 0.070 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2007 | 507 | 0.070 |
Why?
|
| Receptors, Lipoprotein | 2 | 1997 | 88 | 0.070 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 1213 | 0.070 |
Why?
|
| Oligonucleotides | 2 | 2003 | 566 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2018 | 1957 | 0.070 |
Why?
|
| Valine | 1 | 2008 | 408 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 871 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15829 | 0.070 |
Why?
|
| Injections | 1 | 2009 | 832 | 0.070 |
Why?
|
| Physical Exertion | 1 | 1989 | 668 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20556 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2007 | 5863 | 0.070 |
Why?
|
| Cricetulus | 1 | 2008 | 814 | 0.070 |
Why?
|
| Endotoxemia | 1 | 2007 | 196 | 0.070 |
Why?
|
| Fluorescent Dyes | 3 | 2006 | 1901 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2021 | 3769 | 0.070 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2012 | 1085 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 475 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 1759 | 0.070 |
Why?
|
| Fluoresceins | 1 | 2006 | 235 | 0.070 |
Why?
|
| Antibodies, Heterophile | 1 | 2006 | 128 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 591 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3776 | 0.060 |
Why?
|
| Simvastatin | 1 | 2008 | 346 | 0.060 |
Why?
|
| Dietary Fats | 2 | 2011 | 1995 | 0.060 |
Why?
|
| Lipopolysaccharides | 4 | 2007 | 2202 | 0.060 |
Why?
|
| Medicine | 1 | 2014 | 942 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 1169 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2013 | 696 | 0.060 |
Why?
|
| Immunoconjugates | 1 | 2013 | 951 | 0.060 |
Why?
|
| STAT4 Transcription Factor | 1 | 2005 | 93 | 0.060 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2005 | 78 | 0.060 |
Why?
|
| Mitral Valve | 1 | 2014 | 1464 | 0.060 |
Why?
|
| Recombinant Proteins | 6 | 2019 | 6520 | 0.060 |
Why?
|
| Dinoprost | 1 | 2005 | 139 | 0.060 |
Why?
|
| Contrast Media | 2 | 2017 | 5305 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2008 | 597 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2003 | 3965 | 0.060 |
Why?
|
| STAT6 Transcription Factor | 1 | 2005 | 194 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3688 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2008 | 5109 | 0.060 |
Why?
|
| Biomedical Engineering | 2 | 2012 | 286 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3593 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2020 | 6240 | 0.060 |
Why?
|
| Actins | 1 | 2012 | 2051 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 682 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 39062 | 0.060 |
Why?
|
| Polyvinyl Alcohol | 1 | 1985 | 73 | 0.060 |
Why?
|
| Biodegradation, Environmental | 2 | 2000 | 216 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 3621 | 0.060 |
Why?
|
| Immunologic Factors | 2 | 2018 | 1589 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2009 | 1434 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 2456 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 2231 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2008 | 1635 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2005 | 1141 | 0.060 |
Why?
|
| Water | 1 | 2010 | 1409 | 0.060 |
Why?
|
| Obesity | 3 | 2015 | 12934 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2017 | 6223 | 0.060 |
Why?
|
| Research Design | 3 | 2013 | 6174 | 0.060 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2003 | 100 | 0.060 |
Why?
|
| Antihypertensive Agents | 2 | 2016 | 2018 | 0.060 |
Why?
|
| Diet, Atherogenic | 1 | 2003 | 92 | 0.060 |
Why?
|
| Conservation of Energy Resources | 1 | 2003 | 20 | 0.060 |
Why?
|
| Biochemical Phenomena | 1 | 2004 | 58 | 0.060 |
Why?
|
| Hospitalization | 2 | 2021 | 10708 | 0.060 |
Why?
|
| Cardiomyoplasty | 1 | 2003 | 5 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 747 | 0.060 |
Why?
|
| Polyethyleneimine | 1 | 2024 | 68 | 0.060 |
Why?
|
| Drug Stability | 1 | 2004 | 291 | 0.050 |
Why?
|
| Zebrafish | 1 | 2015 | 3005 | 0.050 |
Why?
|
| Acute Coronary Syndrome | 1 | 2016 | 2190 | 0.050 |
Why?
|
| Alloys | 2 | 2019 | 110 | 0.050 |
Why?
|
| Filtration | 1 | 2004 | 228 | 0.050 |
Why?
|
| Micelles | 1 | 2024 | 192 | 0.050 |
Why?
|
| Inulin | 2 | 1997 | 67 | 0.050 |
Why?
|
| Ear Cartilage | 1 | 2023 | 62 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2006 | 4365 | 0.050 |
Why?
|
| Young Adult | 4 | 2022 | 59191 | 0.050 |
Why?
|
| Neutral Red | 1 | 2022 | 9 | 0.050 |
Why?
|
| Cells | 1 | 2004 | 164 | 0.050 |
Why?
|
| Photochemistry | 1 | 2003 | 239 | 0.050 |
Why?
|
| Peptide Biosynthesis | 1 | 2002 | 52 | 0.050 |
Why?
|
| Transfection | 1 | 2011 | 5765 | 0.050 |
Why?
|
| Foam Cells | 2 | 2018 | 68 | 0.050 |
Why?
|
| Rose Bengal | 1 | 2003 | 115 | 0.050 |
Why?
|
| Secondary Prevention | 2 | 2000 | 1470 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2024 | 223 | 0.050 |
Why?
|
| Heart Valve Diseases | 2 | 2003 | 1028 | 0.050 |
Why?
|
| Capillaries | 2 | 2014 | 756 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2006 | 1790 | 0.050 |
Why?
|
| Receptors, Fibronectin | 1 | 2002 | 37 | 0.050 |
Why?
|
| Fibrin | 1 | 2005 | 507 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2010 | 1265 | 0.050 |
Why?
|
| Tetrazoles | 1 | 2008 | 909 | 0.050 |
Why?
|
| Lipoproteins, HDL | 2 | 1997 | 675 | 0.050 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2022 | 86 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 908 | 0.050 |
Why?
|
| Antibodies | 2 | 2002 | 2413 | 0.050 |
Why?
|
| RNA Interference | 1 | 2011 | 2829 | 0.050 |
Why?
|
| Amines | 2 | 2015 | 281 | 0.050 |
Why?
|
| Forecasting | 1 | 2011 | 2924 | 0.050 |
Why?
|
| Ethers | 1 | 2022 | 73 | 0.050 |
Why?
|
| History, Medieval | 1 | 2001 | 62 | 0.050 |
Why?
|
| Trachea | 1 | 2008 | 1089 | 0.050 |
Why?
|
| Benzophenones | 1 | 2022 | 57 | 0.050 |
Why?
|
| Adsorption | 1 | 2002 | 197 | 0.050 |
Why?
|
| Receptor, EphB2 | 1 | 2001 | 26 | 0.050 |
Why?
|
| Models, Statistical | 3 | 2015 | 5074 | 0.050 |
Why?
|
| Immunization | 1 | 2006 | 1217 | 0.050 |
Why?
|
| History, 16th Century | 1 | 2001 | 70 | 0.050 |
Why?
|
| Capsules | 2 | 1993 | 191 | 0.050 |
Why?
|
| Respiratory Mucosa | 1 | 2005 | 438 | 0.050 |
Why?
|
| Autopsy | 2 | 2022 | 1008 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 678 | 0.050 |
Why?
|
| Liver Circulation | 1 | 2022 | 159 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2004 | 488 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2007 | 4512 | 0.050 |
Why?
|
| Tissue Transplantation | 1 | 2002 | 128 | 0.050 |
Why?
|
| Protein Kinases | 2 | 2005 | 1606 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 17878 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 6051 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 1202 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 1998 | 748 | 0.050 |
Why?
|
| Intestines | 1 | 2010 | 1909 | 0.050 |
Why?
|
| Peptides | 3 | 2002 | 4354 | 0.050 |
Why?
|
| History, Ancient | 1 | 2001 | 212 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 2863 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2812 | 0.050 |
Why?
|
| Hyperhomocysteinemia | 1 | 2001 | 118 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 6126 | 0.050 |
Why?
|
| Protein Transport | 1 | 2007 | 1966 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2003 | 348 | 0.050 |
Why?
|
| Calibration | 2 | 2004 | 817 | 0.050 |
Why?
|
| Prognosis | 1 | 2021 | 29601 | 0.050 |
Why?
|
| Thermodynamics | 1 | 2002 | 593 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5304 | 0.050 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2000 | 37 | 0.050 |
Why?
|
| Regeneration | 3 | 2019 | 1505 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1970 | 0.040 |
Why?
|
| Platelet Count | 1 | 2003 | 780 | 0.040 |
Why?
|
| Elastin | 1 | 2002 | 298 | 0.040 |
Why?
|
| Saphenous Vein | 2 | 2019 | 516 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 1443 | 0.040 |
Why?
|
| Interleukins | 1 | 2005 | 783 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2000 | 297 | 0.040 |
Why?
|
| Surface Tension | 1 | 2000 | 43 | 0.040 |
Why?
|
| Equipment Failure Analysis | 1 | 2002 | 843 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 794 | 0.040 |
Why?
|
| Weightlessness | 1 | 1981 | 102 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 661 | 0.040 |
Why?
|
| Cryoultramicrotomy | 1 | 1999 | 16 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 36401 | 0.040 |
Why?
|
| Swimming | 1 | 2001 | 208 | 0.040 |
Why?
|
| Liposomes | 1 | 2003 | 784 | 0.040 |
Why?
|
| Early Diagnosis | 2 | 2016 | 1185 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2000 | 258 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 4533 | 0.040 |
Why?
|
| Protein Folding | 1 | 2003 | 870 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1999 | 201 | 0.040 |
Why?
|
| Cell Count | 1 | 2003 | 1834 | 0.040 |
Why?
|
| Therapeutic Equivalency | 1 | 1999 | 134 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2021 | 223 | 0.040 |
Why?
|
| Phenylephrine | 1 | 2020 | 293 | 0.040 |
Why?
|
| Polyethylenes | 1 | 2022 | 290 | 0.040 |
Why?
|
| Air | 1 | 2000 | 187 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2009 | 3680 | 0.040 |
Why?
|
| Transplantation Immunology | 1 | 2001 | 532 | 0.040 |
Why?
|
| Convection | 1 | 1998 | 30 | 0.040 |
Why?
|
| Comorbidity | 1 | 2014 | 10507 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 2000 | 285 | 0.040 |
Why?
|
| Inflation, Economic | 1 | 1999 | 30 | 0.040 |
Why?
|
| Thorax | 1 | 2022 | 555 | 0.040 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 1998 | 27 | 0.040 |
Why?
|
| Lasers | 1 | 2003 | 952 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2022 | 982 | 0.040 |
Why?
|
| Enteritis | 1 | 2000 | 162 | 0.040 |
Why?
|
| Syndrome | 1 | 2005 | 3268 | 0.040 |
Why?
|
| Fibrosis | 2 | 2021 | 2047 | 0.040 |
Why?
|
| Respiratory System | 1 | 2022 | 563 | 0.040 |
Why?
|
| Vestibule, Labyrinth | 1 | 1981 | 234 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12043 | 0.040 |
Why?
|
| Anisotropy | 1 | 2002 | 1283 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14388 | 0.040 |
Why?
|
| Radiography | 1 | 2009 | 6961 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1248 | 0.040 |
Why?
|
| Locomotion | 1 | 2001 | 388 | 0.040 |
Why?
|
| Probucol | 1 | 1998 | 25 | 0.040 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1998 | 56 | 0.040 |
Why?
|
| Glutaral | 1 | 2018 | 76 | 0.040 |
Why?
|
| Prodrugs | 1 | 2020 | 261 | 0.040 |
Why?
|
| Extracorporeal Circulation | 1 | 1998 | 181 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2006 | 1797 | 0.040 |
Why?
|
| Tricuspid Valve | 1 | 2021 | 409 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2023 | 702 | 0.040 |
Why?
|
| Radiometry | 1 | 2003 | 812 | 0.040 |
Why?
|
| Heparin Antagonists | 1 | 1997 | 34 | 0.040 |
Why?
|
| RNA-Binding Proteins | 2 | 1997 | 1890 | 0.040 |
Why?
|
| Europe | 2 | 2016 | 3415 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2017 | 41464 | 0.040 |
Why?
|
| Ginkgolides | 1 | 1997 | 7 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2019 | 343 | 0.040 |
Why?
|
| Capital Financing | 1 | 2017 | 58 | 0.040 |
Why?
|
| Particle Size | 2 | 2017 | 1648 | 0.040 |
Why?
|
| Eye Movements | 1 | 1981 | 511 | 0.040 |
Why?
|
| Transplants | 1 | 1999 | 206 | 0.040 |
Why?
|
| Models, Econometric | 1 | 2017 | 215 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 1161 | 0.040 |
Why?
|
| Prevalence | 1 | 2014 | 15702 | 0.040 |
Why?
|
| Mitogens | 1 | 1997 | 229 | 0.030 |
Why?
|
| Glycolysis | 1 | 2021 | 835 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2020 | 484 | 0.030 |
Why?
|
| Tritium | 1 | 1997 | 706 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 6188 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 12143 | 0.030 |
Why?
|
| Intestinal Mucosa | 2 | 2005 | 3031 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1997 | 284 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2000 | 645 | 0.030 |
Why?
|
| Bile | 1 | 1997 | 298 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5031 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1997 | 183 | 0.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 244 | 0.030 |
Why?
|
| Chromium Alloys | 1 | 2015 | 71 | 0.030 |
Why?
|
| Gels | 1 | 1997 | 420 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 1997 | 561 | 0.030 |
Why?
|
| Incidence | 1 | 2014 | 21339 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2024 | 1230 | 0.030 |
Why?
|
| Receptors, Peptide | 1 | 1997 | 279 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 2948 | 0.030 |
Why?
|
| Germany | 1 | 2018 | 872 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2005 | 2851 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 3793 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1483 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2023 | 1140 | 0.030 |
Why?
|
| Neutrophils | 2 | 2015 | 3763 | 0.030 |
Why?
|
| Hematocrit | 1 | 1996 | 623 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2019 | 676 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2005 | 2909 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2000 | 1642 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 1996 | 319 | 0.030 |
Why?
|
| Software | 2 | 2015 | 4432 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2012 | 23974 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 1997 | 368 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1996 | 618 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 418 | 0.030 |
Why?
|
| Lactones | 1 | 1997 | 316 | 0.030 |
Why?
|
| Stress, Psychological | 2 | 1990 | 4488 | 0.030 |
Why?
|
| Biophysics | 1 | 1996 | 379 | 0.030 |
Why?
|
| Electroporation | 1 | 1995 | 233 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 416 | 0.030 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 138 | 0.030 |
Why?
|
| Platelet Transfusion | 1 | 1997 | 298 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 1997 | 428 | 0.030 |
Why?
|
| Angioplasty, Balloon, Laser-Assisted | 1 | 1994 | 20 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2015 | 284 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2001 | 1438 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 1996 | 552 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2005 | 2878 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2019 | 1141 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2012 | 11512 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2001 | 4010 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 504 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2015 | 298 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1997 | 1540 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1993 | 71 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 1526 | 0.030 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2015 | 266 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 578 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2020 | 2194 | 0.030 |
Why?
|
| Proteins | 1 | 2008 | 6030 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 1994 | 163 | 0.030 |
Why?
|
| Heparin Lyase | 1 | 1992 | 37 | 0.030 |
Why?
|
| Heart Rate | 2 | 2015 | 4181 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 1992 | 113 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13635 | 0.030 |
Why?
|
| Lipids | 2 | 2018 | 3332 | 0.030 |
Why?
|
| Creatinine | 2 | 2014 | 1895 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 1992 | 47 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 9586 | 0.030 |
Why?
|
| STAT Transcription Factors | 1 | 2013 | 188 | 0.030 |
Why?
|
| Australia | 1 | 2016 | 1249 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 178 | 0.030 |
Why?
|
| Dopamine | 1 | 2020 | 1606 | 0.030 |
Why?
|
| Brain | 2 | 2018 | 27100 | 0.030 |
Why?
|
| alpha-Tocopherol | 1 | 2013 | 126 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 4570 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 2013 | 165 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2013 | 362 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2023 | 2881 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2013 | 248 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2007 | 17630 | 0.030 |
Why?
|
| Vagina | 1 | 1998 | 841 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2013 | 134 | 0.020 |
Why?
|
| Virus Replication | 1 | 2020 | 2427 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1745 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2018 | 1566 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2015 | 311 | 0.020 |
Why?
|
| Japan | 1 | 2016 | 1372 | 0.020 |
Why?
|
| Graft Survival | 1 | 2002 | 3814 | 0.020 |
Why?
|
| Metals | 1 | 2016 | 719 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2018 | 2048 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2013 | 433 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 1992 | 321 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2015 | 683 | 0.020 |
Why?
|
| beta Carotene | 1 | 2013 | 523 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2005 | 3954 | 0.020 |
Why?
|
| Administration, Topical | 1 | 1993 | 703 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2011 | 63 | 0.020 |
Why?
|
| Phytotherapy | 1 | 2013 | 296 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 1998 | 967 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2016 | 5965 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 452 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1739 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 12116 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2020 | 2689 | 0.020 |
Why?
|
| Oxidative Stress | 2 | 2014 | 3115 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2014 | 1081 | 0.020 |
Why?
|
| Metanephrine | 1 | 2009 | 25 | 0.020 |
Why?
|
| Methionine | 1 | 1992 | 572 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 1997 | 7847 | 0.020 |
Why?
|
| Cathepsins | 1 | 2011 | 241 | 0.020 |
Why?
|
| Risk | 2 | 2015 | 9603 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2015 | 982 | 0.020 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 655 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8619 | 0.020 |
Why?
|
| Hindlimb | 1 | 2012 | 513 | 0.020 |
Why?
|
| Cadaver | 1 | 2014 | 1358 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 1997 | 1182 | 0.020 |
Why?
|
| Patient Selection | 2 | 2018 | 4237 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2014 | 1083 | 0.020 |
Why?
|
| Temperature | 2 | 1987 | 2224 | 0.020 |
Why?
|
| Base Sequence | 3 | 1995 | 12420 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2023 | 5292 | 0.020 |
Why?
|
| Oncogenes | 1 | 1995 | 1220 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 1642 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 834 | 0.020 |
Why?
|
| Mortality | 1 | 2020 | 2899 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2015 | 1186 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2016 | 2916 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2003 | 3245 | 0.020 |
Why?
|
| Propensity Score | 1 | 2015 | 1912 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1503 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2013 | 1068 | 0.020 |
Why?
|
| Fetal Death | 1 | 2009 | 435 | 0.020 |
Why?
|
| Exercise | 2 | 2023 | 5886 | 0.020 |
Why?
|
| Fasting | 1 | 1994 | 1603 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3836 | 0.020 |
Why?
|
| Drainage | 1 | 1993 | 1156 | 0.020 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2013 | 575 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2120 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2005 | 22153 | 0.020 |
Why?
|
| Scavenger Receptors, Class B | 2 | 1997 | 85 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2009 | 582 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2013 | 1436 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1997 | 2234 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2009 | 407 | 0.020 |
Why?
|
| Receptors, Scavenger | 2 | 1997 | 123 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 8603 | 0.020 |
Why?
|
| Colon | 1 | 2015 | 1791 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1996 | 2495 | 0.020 |
Why?
|
| Thrombomodulin | 1 | 2007 | 105 | 0.020 |
Why?
|
| Warfarin | 1 | 2015 | 1477 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1986 | 2088 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 13383 | 0.020 |
Why?
|
| Colitis | 1 | 2015 | 1234 | 0.020 |
Why?
|
| Pregnancy | 2 | 2023 | 29869 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1994 | 4845 | 0.020 |
Why?
|
| Mechanoreceptors | 1 | 2007 | 186 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2570 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2014 | 2298 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2007 | 517 | 0.020 |
Why?
|
| Phthalic Anhydrides | 1 | 1985 | 3 | 0.020 |
Why?
|
| Streptozocin | 1 | 2005 | 193 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1989 | 763 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2005 | 184 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2000 | 9171 | 0.020 |
Why?
|
| Stem Cells | 1 | 2018 | 3514 | 0.020 |
Why?
|
| Chemistry | 1 | 1985 | 346 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1985 | 506 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2005 | 319 | 0.010 |
Why?
|
| Methods | 1 | 1985 | 1065 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 360 | 0.010 |
Why?
|
| Skin | 2 | 2014 | 4472 | 0.010 |
Why?
|
| Child | 3 | 2023 | 80089 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4269 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2009 | 1524 | 0.010 |
Why?
|
| Transgenes | 1 | 2007 | 1008 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 451 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 2252 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7403 | 0.010 |
Why?
|
| Suction | 1 | 2004 | 266 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 2533 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2009 | 1178 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1756 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 1265 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1624 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 1923 | 0.010 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2002 | 167 | 0.010 |
Why?
|
| Dyspnea | 1 | 2009 | 1347 | 0.010 |
Why?
|
| Headache | 1 | 2009 | 1255 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2004 | 2746 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 2002 | 241 | 0.010 |
Why?
|
| Kinesthesis | 1 | 1981 | 22 | 0.010 |
Why?
|
| Adolescent | 2 | 2022 | 88247 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1575 | 0.010 |
Why?
|
| DNA | 1 | 2014 | 7196 | 0.010 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2000 | 45 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 2575 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 2410 | 0.010 |
Why?
|
| Pre-Eclampsia | 1 | 2009 | 1230 | 0.010 |
Why?
|
| Acceleration | 1 | 1981 | 189 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2000 | 310 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2004 | 701 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 5789 | 0.010 |
Why?
|
| Orientation | 1 | 1981 | 321 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5334 | 0.010 |
Why?
|
| Glucagon-Like Peptides | 1 | 2000 | 153 | 0.010 |
Why?
|
| Consensus | 1 | 2008 | 3117 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 2118 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2007 | 2135 | 0.010 |
Why?
|
| Neutrophil Infiltration | 1 | 2000 | 390 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2000 | 562 | 0.010 |
Why?
|
| Jejunum | 1 | 2000 | 472 | 0.010 |
Why?
|
| Space Flight | 1 | 1981 | 216 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 1386 | 0.010 |
Why?
|
| Kinins | 1 | 1997 | 14 | 0.010 |
Why?
|
| Endothelins | 1 | 1997 | 127 | 0.010 |
Why?
|
| Glucose Oxidase | 1 | 1996 | 18 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 1998 | 293 | 0.010 |
Why?
|
| Chronic Disease | 3 | 1996 | 9310 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 1551 | 0.010 |
Why?
|
| Iontophoresis | 1 | 1995 | 74 | 0.010 |
Why?
|
| Placebos | 1 | 1999 | 1667 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13442 | 0.010 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1994 | 58 | 0.010 |
Why?
|
| Ketanserin | 1 | 1994 | 24 | 0.010 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1994 | 65 | 0.010 |
Why?
|
| Nitroarginine | 1 | 1994 | 66 | 0.010 |
Why?
|
| Calcimycin | 1 | 1994 | 213 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1997 | 618 | 0.010 |
Why?
|
| Thromboxane A2 | 1 | 1994 | 88 | 0.010 |
Why?
|
| Morbidity | 1 | 2000 | 1750 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1994 | 272 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1994 | 229 | 0.010 |
Why?
|
| Indomethacin | 1 | 1994 | 323 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1994 | 422 | 0.010 |
Why?
|
| Safety | 1 | 1998 | 1149 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1994 | 283 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 1995 | 712 | 0.010 |
Why?
|
| Adenoviridae | 1 | 1997 | 1084 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2015 | 42193 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8516 | 0.010 |
Why?
|
| Stroke | 1 | 2015 | 9715 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1994 | 629 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 1992 | 78 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1996 | 852 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 2659 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 7390 | 0.010 |
Why?
|
| Arginine | 1 | 1994 | 933 | 0.010 |
Why?
|
| Procainamide | 1 | 1989 | 56 | 0.010 |
Why?
|
| Serotonin | 1 | 1994 | 1041 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1989 | 181 | 0.010 |
Why?
|
| Body Weight | 1 | 2000 | 4615 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1996 | 1946 | 0.010 |
Why?
|
| Lipoproteins | 1 | 1994 | 879 | 0.010 |
Why?
|
| Glycosuria | 1 | 1986 | 44 | 0.000 |
Why?
|
| Lidocaine | 1 | 1989 | 538 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1993 | 20988 | 0.000 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 1700 | 0.000 |
Why?
|
| Survival Rate | 1 | 1998 | 12719 | 0.000 |
Why?
|
| Linear Models | 1 | 1994 | 5866 | 0.000 |
Why?
|
| Eating | 1 | 1990 | 1535 | 0.000 |
Why?
|
| Sleep Deprivation | 1 | 1990 | 847 | 0.000 |
Why?
|